Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
BMC Biotechnology
|
March 24, 2016
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor
Rebecca J Linger, Esther J Belikoff, Ying Yan, et al.
Science (New York, N.Y.)
|
October 12, 2002
Subthalamic GAD gene therapy in a Parkinson's disease rat model
Jia Luo, Michael G Kaplitt, Helen L Fitzsimons, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 26, 2000
Personality disorders in elderly patients with dysthymic disorder
D P Devanand, N Turret, B J Moody, et al.
Molecular Microbiology
|
November 25, 2016
SymB and SymC, two membrane associated proteins, are required for Epichloë festucae hyphal cell-cell fusion and maintenance of a mutualistic interaction with Lolium perenne
Kimberly A Green, Yvonne Becker, Aiko Tanaka, et al.
Archives of General Psychiatry
|
May 12, 2000
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities
H A Sackeim, J Prudic, D P Devanand, et al.
Gene Therapy
|
February 13, 2004
Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior
A J Noordmans, D K Song, C J Noordmans, et al.
The New England Journal of Medicine
|
March 25, 1993
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy
H A Sackeim, J Prudic, D P Devanand, et al.
Lancet (London, England)
|
June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Science (New York, N.Y.)
|
February 26, 2000
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
M J During, C W Symes, P A Lawlor, et al.
Nature Medicine
|
August 20, 2003
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Matthew J During, Lei Cao, David S Zuzga, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
BMC Biotechnology
|
March 24, 2016
Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor
Rebecca J Linger, Esther J Belikoff, Ying Yan, et al.
Science (New York, N.Y.)
|
October 12, 2002
Subthalamic GAD gene therapy in a Parkinson's disease rat model
Jia Luo, Michael G Kaplitt, Helen L Fitzsimons, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
July 26, 2000
Personality disorders in elderly patients with dysthymic disorder
D P Devanand, N Turret, B J Moody, et al.
Molecular Microbiology
|
November 25, 2016
SymB and SymC, two membrane associated proteins, are required for Epichloë festucae hyphal cell-cell fusion and maintenance of a mutualistic interaction with Lolium perenne
Kimberly A Green, Yvonne Becker, Aiko Tanaka, et al.
Archives of General Psychiatry
|
May 12, 2000
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities
H A Sackeim, J Prudic, D P Devanand, et al.
Gene Therapy
|
February 13, 2004
Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior
A J Noordmans, D K Song, C J Noordmans, et al.
The New England Journal of Medicine
|
March 25, 1993
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy
H A Sackeim, J Prudic, D P Devanand, et al.
Lancet (London, England)
|
June 26, 2007
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
Michael G Kaplitt, Andrew Feigin, Chengke Tang, et al.
Science (New York, N.Y.)
|
February 26, 2000
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
M J During, C W Symes, P A Lawlor, et al.
Nature Medicine
|
August 20, 2003
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Matthew J During, Lei Cao, David S Zuzga, et al.
Page
of 4